Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
1.070
-0.020 (-1.83%)
At close: Mar 6, 2026, 4:00 PM EST
1.112
+0.042 (3.89%)
After-hours: Mar 6, 2026, 6:28 PM EST
Hyperfine Employees
Hyperfine had 111 employees as of December 31, 2024. The number of employees decreased by 20 or -15.27% compared to the previous year.
Employees
111
Change (1Y)
-20
Growth (1Y)
-15.27%
Revenue / Employee
$95,414
Profits / Employee
-$360,829
Market Cap
103.97M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 111 | -20 | -15.27% |
| Dec 31, 2023 | 131 | -5 | -3.68% |
| Dec 31, 2022 | 136 | -57 | -29.53% |
| Dec 31, 2021 | 193 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Neuronetics | 716 |
| Treace Medical Concepts | 477 |
| Xtant Medical Holdings | 232 |
| AVITA Medical | 226 |
| Apyx Medical | 220 |
| Baird Medical Investment Holdings | 143 |
| LENSAR | 140 |
| MaxCyte | 114 |
HYPR News
- 2 days ago - Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 - Business Wire
- 5 weeks ago - Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System's Enhanced Stroke Detection Capabilities - Business Wire
- 6 weeks ago - Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics - Business Wire
- 7 weeks ago - Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents - Business Wire
- 7 weeks ago - Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 2 months ago - Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care - Business Wire
- 2 months ago - Hyperfine Announces Regulatory Approval of the Swoop® System in India - Business Wire
- 2 months ago - Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System - Business Wire